Analyst Consensus ?
ConsensusBuy27 ratings
Bullish2488.9%
Neutral311.1%
Bearish00.0%
KKR & Co. Inc. · KKR · FY2025 Q1 · Calendar Q2 2025
KKR Highlights Fee Growth, Fundraising and a Large Monetization Pipeline
KKR's current analysis supports a constructive operating thesis: fee growth, fundraising, recurring earnings, strategic holdings, and insurance expansion provide multiple growth drivers. The thesis remains exposed to deployment timing, monetization conditions, tariffs, and credit-market risk.
Reported Before market openNYSEFinancial Services
$81.41B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $1.14
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $1.71B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+0.2%
Event window
SPY move
+0.7%
Same window
Abnormal move
-0.5%
Stock minus SPY
Volume
0.7×
Versus trailing sessions
Subsequent drift
+6.1%
Up to 20 sessions
KKRSPY benchmark
Ask FN2 about KKR FY2025 Q1
Transcript, numbers and history already loaded
What drove KKR's +0.2% move after FY2025 Q1 earnings?What changed in KKR's guidance and outlook in FY2025 Q1?Give me the bull and bear case for KKR after FY2025 Q1 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior quarter, the analysis shifts from record fundraising and new product launches to Q1 execution: fee-related earnings rose 22%, $31 billion was raised, strategic holdings expanded with Karo Healthcare, and the monetization pipeline exceeded $800 million.
Guidance delta
Maintained; management emphasized continued fundraising, deployment, monetization, and platform expansion.
Key takeaways
- Fee-related earnings grew 22% year over year, with a 69% FRE margin.
- KKR raised $31 billion in the quarter, while recurring earnings represented roughly 80% of pretax earnings.
- The monetization pipeline exceeded $800 million, with at least $250 million expected in Q2.
Management priorities
- Expand private-equity and real-assets vehicles and the K-Series wealth platform.
- Increase strategic holdings and broaden insurance alternative-asset exposure.
- Scale asset-based finance, private credit, and capital-markets capabilities.
Follow KKR with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$90.67Previous close
$63Low
$119.4Average
$190High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 7, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Oppenheimer | Outperform | Outperform | Maintain | Aug 27, 2026 |
| Argus Research | Buy | Buy | Maintain | Aug 4, 2026 |
| TD Cowen | Hold | Hold | Maintain | Aug 3, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 3, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 31, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 31, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 21, 2026 |
| HSBC | Buy | Buy | Maintain | Jul 20, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 13, 2026 |
| UBS | Buy | Buy | Maintain | May 6, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Apr 7, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 7, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 13, 2025 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Aug 4, 2025 |
| JMP Securities | Market Perform | Market Outperform | Downgrade | Jul 14, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 11, 2025 |
| B of A Securities | Buy | Buy | Maintain | Apr 4, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Nov 11, 2024 |
| Jefferies | Buy | Buy | Maintain | May 9, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | May 9, 2023 |
| CFRA | Buy | Hold | Upgrade | May 11, 2020 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | May 7, 2020 |
| Bank of America | Buy | Neutral | Upgrade | Sep 23, 2019 |
| Argus | Buy | Hold | Upgrade | Oct 26, 2018 |
| PiperJaffray | Overweight | Overweight | Maintain | Jun 3, 2015 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | May 13, 2014 |
| Bernstein | Outperform | Outperform | Maintain | Apr 3, 2014 |
Named analyst price targets
Upside is calculated against the persisted previous close $90.67. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Daniel Welden | $97 | $91.24 | +7.0% | Oct 1, 2026 |
| UBS | Michael Brown | $123 | $106.88 | +35.7% | Sep 1, 2026 |
| Piper Sandler | Crispin Love | $128 | $114.98 | +41.2% | Aug 14, 2026 |
| Deutsche Bank | Brian Bedell | $116 | $102.8 | +27.9% | Aug 3, 2026 |
| BMO Capital | Brennan Hawken | $118 | $101.43 | +30.1% | Aug 3, 2026 |
| RBC Capital | Analyst unavailable | $134 | $100.62 | +47.8% | Jul 31, 2026 |
| Barclays | Benjamin Budish | $135 | $100.98 | +48.9% | Jul 31, 2026 |
| Morgan Stanley | Analyst unavailable | $147 | $97.2 | +62.1% | Jul 21, 2026 |
| HSBC | Analyst unavailable | $121 | $100.94 | +33.5% | Jul 20, 2026 |
| BMO Capital | Brennan Hawken | $112 | $96.8 | +23.5% | Jul 13, 2026 |
| Barclays | Analyst unavailable | $124 | $96.27 | +36.8% | Jul 10, 2026 |
| UBS | Analyst unavailable | $126 | $101.4 | +39.0% | May 6, 2026 |
| Barclays | Analyst unavailable | $122 | $102 | +34.6% | May 6, 2026 |
| Morgan Stanley | Analyst unavailable | $153 | $106.76 | +68.7% | Apr 21, 2026 |
| Evercore ISI | Analyst unavailable | $119 | $106.68 | +31.2% | Apr 21, 2026 |
| RBC Capital | Analyst unavailable | $137 | $92.19 | +51.1% | Feb 23, 2026 |
| UBS | Analyst unavailable | $125 | $102.33 | +37.9% | Feb 20, 2026 |
| Morgan Stanley | Analyst unavailable | $177 | $102.46 | +95.2% | Feb 6, 2026 |
| Evercore ISI | Analyst unavailable | $125 | $102.58 | +37.9% | Feb 6, 2026 |
| Oppenheimer | Chris Kotowski | $187 | $102.04 | +106.2% | Feb 6, 2026 |
| Barclays | Analyst unavailable | $136 | $99.17 | +50.0% | Feb 6, 2026 |
| HSBC | Analyst unavailable | $144 | $116 | +58.8% | Jan 27, 2026 |
| Morgan Stanley | Analyst unavailable | $176 | $118.65 | +94.1% | Jan 27, 2026 |
| Oppenheimer | Analyst unavailable | $190 | $125.76 | +109.6% | Jan 20, 2026 |
| UBS | Analyst unavailable | $168 | $129.61 | +85.3% | Jan 13, 2026 |
| Barclays | Analyst unavailable | $159 | $133.64 | +75.4% | Jan 9, 2026 |
| Barclays | Analyst unavailable | $169 | $142.74 | +86.4% | Dec 12, 2025 |
| UBS | Michael Brown | $176 | $141.54 | +94.1% | Dec 11, 2025 |
| Barclays | Benjamin Budish | $154 | $120.11 | +69.8% | Nov 11, 2025 |
| Barclays | Analyst unavailable | $151 | $118.33 | +66.5% | Nov 3, 2025 |
| Morgan Stanley | Analyst unavailable | $166 | $122.6 | +83.1% | Oct 21, 2025 |
| Piper Sandler | Analyst unavailable | $155 | $124.42 | +70.9% | Oct 7, 2025 |
| Wolfe Research | Steven Chubak | $159 | $143.05 | +75.4% | Jul 10, 2025 |
| HSBC | Vikram Gandhi | $119 | $104.23 | +31.2% | Apr 15, 2025 |
| Wells Fargo | Analyst unavailable | $141 | $116.71 | +55.5% | Mar 20, 2025 |
| Wolfe Research | Steven Chubak | $185 | $150.92 | +104.0% | Jan 3, 2025 |
| JMP Securities | Devin Ryan | $150 | $131.35 | +65.4% | Oct 9, 2024 |
| Goldman Sachs | Alexander Blostein | $137 | $132.6 | +51.1% | Sep 24, 2024 |
| HSBC | Vikram Gandhi | $148 | $127.97 | +63.2% | Sep 18, 2024 |
| Redburn Partners | Nicholas Watts | $153 | $122.15 | +68.7% | Aug 27, 2024 |
| Oppenheimer | Chris Kotowski | $128 | $123.45 | +41.2% | Aug 1, 2024 |
| Evercore ISI | Glenn Schorr | $117 | $110.74 | +29.0% | Jul 15, 2024 |
| Oppenheimer | Chris Kotowski | $121 | $104.98 | +33.5% | Jul 8, 2024 |
| Deutsche Bank | Brian Bedell | $129 | $109.72 | +42.3% | Jun 10, 2024 |
| Jefferies | Daniel Fannon | $113 | $99.67 | +24.6% | May 9, 2024 |
| Deutsche Bank | Brian Bedell | $120 | $95.12 | +32.3% | May 2, 2024 |
| JMP Securities | Devin Ryan | $115 | $95.51 | +26.8% | Apr 15, 2024 |
| Barclays | Benjamin Budish | $113 | $100.93 | +24.6% | Apr 8, 2024 |
| Deutsche Bank | Brian Bedell | $122 | $98.17 | +34.6% | Apr 5, 2024 |
| Loop Capital Markets | Rufus Hone | $74 | $61.19 | -18.4% | Aug 8, 2023 |
| Wells Fargo | Analyst unavailable | $65 | $58.94 | -28.3% | Feb 8, 2023 |
| JMP Securities | Analyst unavailable | $72 | $49.64 | -20.6% | Jan 10, 2023 |
| Deutsche Bank | Analyst unavailable | $65 | $54.71 | -28.3% | Nov 15, 2022 |
| Deutsche Bank | Analyst unavailable | $68 | $56.79 | -25.0% | Aug 12, 2022 |
| Morgan Stanley | Analyst unavailable | $60 | $50.4 | -33.8% | Jul 19, 2022 |
| Deutsche Bank | Analyst unavailable | $66 | $46.17 | -27.2% | Jul 13, 2022 |
| Wells Fargo | Analyst unavailable | $63 | $45.53 | -30.5% | Jul 13, 2022 |
| JMP Securities | Analyst unavailable | $80 | $47.72 | -11.8% | Jul 12, 2022 |
| Piper Sandler | Analyst unavailable | $80 | $47.55 | -11.8% | Jul 11, 2022 |
| Goldman Sachs | Analyst unavailable | $63 | $47.35 | -30.5% | Jun 29, 2022 |
| Deutsche Bank | Brian Bedell | $79 | $50.46 | -12.9% | May 19, 2022 |
| Morgan Stanley | Analyst unavailable | $72 | $50.93 | -20.6% | May 10, 2022 |
| Wells Fargo | Analyst unavailable | $72 | $54.44 | -20.6% | May 4, 2022 |
| Morgan Stanley | Analyst unavailable | $71 | $58.18 | -21.7% | Apr 20, 2022 |
| Wells Fargo | Analyst unavailable | $73 | $56.13 | -19.5% | Apr 19, 2022 |
| Citigroup | William Katz | $81.5 | $55.25 | -10.1% | Apr 16, 2022 |
| Piper Sandler | Sumeet Mody | $91 | $80.74 | +0.4% | Nov 4, 2021 |
| BMO Capital | James Fotheringham | $83 | $65.61 | -8.5% | Aug 4, 2021 |
| Barclays | Jeremy Campbell | $63 | $57.59 | -30.5% | May 5, 2021 |
Track every rating change on KKR the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationKKR & Co. Inc. is a prominent global investment powerhouse, deeply engaged in both private equity and real estate. The firm's diverse investment strategies encompass direct capital deployment as well as fund-of-funds approaches, specializing in corporate acquisitions, leveraged and management buyouts, growth equity, and a range of special situations including credit, distressed assets, and turnarounds. They also target mature and mezzanine financing opportunities, spanning companies across the lower and middle market segments. While opportunistic across all industries, KKR exhibits a keen focus on technology sectors, including software, cybersecurity, semiconductors, consumer electronics, the Internet of Things (IoT), internet services, IT infrastructure, and FinTech. Their extensive portfolio also encompasses energy, infrastructure, and a broad array of real estate ventures.…
Historical context
All KKR earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FDS FactSet Research Systems Inc. | FY2026 Q4 · Calendar Q3 2026 | +3.9% | +3.8% | FactSet reports record FY26 results as AI and MCP adoption accelerate |
| PUK Prudential plc | FY2026 Q2 · Calendar Q3 2026 | -40.9% | -0.5% | Prudential sustains growth and capital returns focus in H1 2026 |
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
| RY Royal Bank of Canada | FY2026 Q3 · Calendar Q3 2026 | +6.2% | -1.3% | RBC reports record Q3 earnings while investing for growth |
| AFRM Affirm Holdings, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1230.3% | +0.3% | Affirm's most profitable quarter shifts focus to product execution |
Latest beats and misses
Who reports nextBeat on EPS
- LWFY2027 Q1 · October 6, 2026+27.8% EPS+7.5% move
- RPMFY2027 Q1 · October 6, 2026+1.5% EPS+3.2% move
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
Get the KKR recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-04-17T00:02:52.217204+00:00
- Polygon adjusted daily market bars · 2026-10-07T09:00:45.232642+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-07T09:00:45.228888+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-07. For educational purposes only; not investment advice.